// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "LC individual mass WARRANTY INFORMATION ISA CPTAC PATCH NCBI source name_ and _assay name PTM age II alkylation reagent VCF CLO MS:1001251 biosample accession number RIGHTS HEREIN disease stage MAGE FITNESS RAW HANCESTRO organism part exclamation PSI EBI EXPRESS CF file your INITIATIVE cell type biological replicate EW FOR MINOR PO replicate fractionation method BUT MT III source name IMPLIED REQUIRES proteomics data acquisition method FDR TA label MAY depletion SRM PMID XML INFRINGE IS PARTICULAR PS IMPORTANT WILL HF DOID CV OF reduction reagent MUST AC JA collision energy RECOMMENDED CELL MIAME disease TO NOT NT MONDO SH SHOULD sex ENVO TIP WARRANTIES DIA NOTE URL MAJOR RFC QY STANDARDS fraction identifier RECOMMEND HUPO MHC EFO pooled sample organism BTO cleavage agent details DJ README ALL BMC BRENDA SN spiked compound developmental stage NCE URI ancestry category COULD LIMITED CN IAA XL HTML CT BE DTT ... ANY UBERON ROW USE PURPOSE PRM REQUIRED HCD ID SHALL DDA SILAC LI PEPTIDESEQ CL sample OR CS DISCLAIMS VK characteristics PROTEOMICS PP technical replicate dissociation method ZFA OPTIONAL instrument TAB SWATH THAT PRIDE:0000659 TMT AS PRIDE PMCID SP MC INCLUDING IDF COLUMN THE PATO data file MS MOD MERCHANTABILITY SDRF EM CID"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "LC individual mass WARRANTY INFORMATION ISA CPTAC PATCH NCBI PTM age II alkylation reagent VCF CLO MS:1001251 biosample accession number RIGHTS HEREIN disease stage MAGE FITNESS RAW HANCESTRO organism part PSI EBI EXPRESS CF INITIATIVE cell type biological replicate EW FOR MINOR PO fractionation method BUT MT III IMPLIED REQUIRES proteomics data acquisition method FDR TA label MAY depletion SRM PMID INFRINGE IS PARTICULAR PS WILL HF DOID CV OF reduction reagent MUST AC JA collision energy RECOMMENDED CELL MIAME disease TO NOT NT SH MONDO SHOULD sex ENVO WARRANTIES DIA URL STANDARDS MAJOR RFC QY fraction identifier RECOMMEND HUPO MHC EFO pooled sample organism BTO cleavage agent details DJ README ALL BMC BRENDA SN spiked compound NCE URI ancestry category COULD LIMITED CN IAA XL HTML CT BE DTT ... ANY UBERON ROW USE PURPOSE PRM REQUIRED HCD SHALL DDA SILAC LI PEPTIDESEQ CL OR CS DISCLAIMS VK PROTEOMICS PP technical replicate dissociation method ZFA OPTIONAL instrument TAB SWATH THAT PRIDE:0000659 TMT AS PRIDE PMCID SP MC INCLUDING IDF COLUMN THE PATO data file MS MOD MERCHANTABILITY SDRF EM CID"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "individual PATO:0001340 CL:0000182 UBERON:0000178 NCBI PTM age UBERON:0000955 PATO:0000383 DSS CL:0000813 HANCESTRO MONDO:0005148 APP organism part UBERON:0000948 exclamation CL:0000624 MONDO:0005105 UBERON:0002107 CML cell type biological replicate compound PO COVID MONDO:0004946 MONDO:0005180 source name UBERON:0001359 depletion MAY PDX CL:0000236 NSG IMPORTANT UBERON:0002097 DOID lib CL:0000235 MUST synthetic peptide CL:0000788 CL:0000625 UBERON:0002048 disease CL:0000576 MONDO UBERON:0001969 SHOULD UBERON:0001977 sex TIP CL:0000913 MONDO:0004975 URL NOTE CL:0000623 CL:0000451 CL:0000787 MONDO:0100096 EFO organism ALL UBERON:0002113 PATO:0000461 developmental stage CSF ancestry category xenograft MONDO:0008383 NK CL:0000815 UBERON:0000310 CL:0000057 UBERON MONDO:0004989 CL:0000232 MONDO:0005138 ID UBERON:0001088 CL enrichment process CL:0000066 MONDO:0005301 MONDO:0005575 disease model PATO:0000384 CL:0000084 CL:0000540 CL:0000898 CL:0000233 PATO SDRF UBERON:0001155"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "individual PATO:0001340 CL:0000182 UBERON:0000178 NCBI PTM age UBERON:0000955 PATO:0000383 DSS CL:0000813 HANCESTRO MONDO:0005148 APP organism part UBERON:0000948 CL:0000624 MONDO:0005105 UBERON:0002107 CML cell type biological replicate compound PO COVID MONDO:0004946 MONDO:0005180 source name UBERON:0001359 depletion MAY PDX CL:0000236 NSG UBERON:0002097 DOID CL:0000235 MUST synthetic peptide CL:0000788 CL:0000625 UBERON:0002048 disease CL:0000576 MONDO UBERON:0001969 SHOULD UBERON:0001977 sex CL:0000913 MONDO:0004975 URL CL:0000623 CL:0000451 CL:0000787 MONDO:0100096 EFO organism ALL UBERON:0002113 PATO:0000461 developmental stage CSF ancestry category xenograft MONDO:0008383 NK CL:0000815 UBERON:0000310 CL:0000057 UBERON MONDO:0004989 CL:0000232 MONDO:0005138 ID UBERON:0001088 CL enrichment process CL:0000066 MONDO:0005301 MONDO:0005575 disease model PATO:0000384 CL:0000084 CL:0000540 CL:0000898 CL:0000233 PATO SDRF UBERON:0001155"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "GDPR individual NCIT:C71732 age II alcohol consumption treatment ACE disease stage medication history NCIT:C14169 MONDO:0005148 HANCESTRO organism part NCIT:C53554 ER exclamation HANCESTRO:0005 weight NCIT:C18213 Dukes stage PD compound Ann Arbor stage dose smoking status HANCESTRO:0010 NCIT:C53555 CHEBI:27899 MONDO:0002050 pregnancy status NCIT:C18206 III secondary condition height NCIT:C14174 HIPAA TNM NCIT:C14167 HANCESTRO:0009 IMPORTANT NCIT:C15313 NCIT:C68804 AJCC CHEBI:41774 NCIT:C81328 prior treatment NCIT:C28077 NCIT:C53553 MONDO:0004979 tumor grade MONDO:0005044 NCIT:C65108 disease NCIT:C16358 MONDO:0011122 NCIT:C4870 MONDO sex NCIT:C27971 NCIT:C27970 sampling time point BMI NOTE time post treatment NCIT:C15445 NCIT:C15262 EFO organism menopausal status NCIT:C28079 NCIT:C27966 NCIT:C62723 CHEBI:28748 gestational age NCIT:C53556 ancestry category NCIT:C14168 NCIT:C65107 IV NCIT breast cancer subtype body mass index CHEBI:6801 ID diet HANCESTRO:0006 NCIT:C81327 NCIT:C18058 NCIT:C28078 NCIT:C15329 NCIT:C15632 NCI pre-existing condition PR treatment response PREFERRED NCIT:C28076 ethnicity MONDO:0005300 NCIT:C65106 MONDO:0004995 UO treatment status SDRF NCIT:C28054 TNM staging"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "GDPR individual NCIT:C71732 age II alcohol consumption treatment ACE disease stage medication history NCIT:C14169 MONDO:0005148 HANCESTRO organism part NCIT:C53554 ER HANCESTRO:0005 weight NCIT:C18213 Dukes stage PD compound Ann Arbor stage dose smoking status HANCESTRO:0010 NCIT:C53555 CHEBI:27899 MONDO:0002050 pregnancy status NCIT:C18206 III secondary condition height NCIT:C14174 HIPAA TNM NCIT:C14167 HANCESTRO:0009 NCIT:C15313 NCIT:C68804 AJCC CHEBI:41774 NCIT:C81328 prior treatment NCIT:C28077 NCIT:C53553 MONDO:0004979 tumor grade MONDO:0005044 NCIT:C65108 disease NCIT:C16358 MONDO:0011122 NCIT:C4870 MONDO sex NCIT:C27971 NCIT:C27970 sampling time point BMI time post treatment NCIT:C15445 NCIT:C15262 EFO organism menopausal status NCIT:C28079 NCIT:C27966 NCIT:C62723 CHEBI:28748 gestational age NCIT:C53556 ancestry category NCIT:C14168 NCIT:C65107 IV NCIT breast cancer subtype body mass index CHEBI:6801 ID diet HANCESTRO:0006 NCIT:C81327 NCIT:C18058 NCIT:C28078 NCIT:C15329 NCIT:C15632 NCI pre-existing condition PR treatment response PREFERRED NCIT:C28076 ethnicity MONDO:0005300 NCIT:C65106 MONDO:0004995 UO treatment status SDRF NCIT:C28054 TNM staging"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "TIP proteomexchange accession number MS:1001309 DIA PRM REQUIRED LTQ ID DDA URL UNIMOD:737 NOTE TOF SILAC fraction identifier MS2 analyzer type MM MS:1001303 proteomics data acquisition method TA label fragment mass tolerance MSD SRM sample file uri CS ST ELISA IMPORTANT TS cleavage agent details PP MS:1001251 MS1 scan range scan window lower limit technical replicate HF precursor mass tolerance instrument RAW fraction MUST UNIMOD AC PSI UNIMOD:4 UNIMOD:35 exclamation URI RECOMMENDED MRM MS:1001313 RPPA CF KR modification parameters TMT UNIMOD:1 PRIDE XL MGF SCIEX FTP data file UNIMOD:21 MS MOD NT SDRF MS:1001306 MS:1001917 scan window upper limit SHOULD PRIDE:0000663 MT"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "proteomexchange accession number MS:1001309 DIA PRM REQUIRED LTQ ID DDA URL UNIMOD:737 fraction identifier TOF SILAC MS2 analyzer type MM MS:1001303 proteomics data acquisition method TA label fragment mass tolerance MSD SRM file uri CS ST ELISA TS cleavage agent details PP MS:1001251 MS1 scan range scan window lower limit technical replicate HF precursor mass tolerance instrument RAW MUST UNIMOD AC PSI UNIMOD:4 UNIMOD:35 URI RECOMMENDED MRM MS:1001313 RPPA CF KR modification parameters TMT UNIMOD:1 PRIDE XL MGF SCIEX FTP data file UNIMOD:21 MS MOD NT SDRF MS:1001306 MS:1001917 scan window upper limit SHOULD PRIDE:0000663 MT"
  }
];
